StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Invivyd's price to book ratio was 1.0× on Nov 11, 2026, against 5.6× a year earlier. Over the last 5 years it ranged from 0.3× to 5.7×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.0×−4.7
2025Dec 31, 20255.7×+5.1
2024Dec 31, 20240.6×−1.1
2023Dec 29, 20231.8×+1.3
2022Dec 30, 20220.4×−0.8
2021Dec 31, 20211.3×–

More Invivyd figures

See a number that looks wrong?